Review



tet plko puro plasmid  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Addgene inc tet plko puro plasmid
    (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably <t>transfected</t> <t>with</t> <t>Tet-pLKO-puro</t> plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.
    Tet Plko Puro Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 668 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tet plko puro plasmid/product/Addgene inc
    Average 96 stars, based on 668 article reviews
    tet plko puro plasmid - by Bioz Stars, 2026-05
    96/100 stars

    Images

    1) Product Images from "Human PARPs modify RNA nucleobases in vitro and in cells"

    Article Title: Human PARPs modify RNA nucleobases in vitro and in cells

    Journal: bioRxiv

    doi: 10.64898/2026.03.31.715305

    (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably transfected with Tet-pLKO-puro plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.
    Figure Legend Snippet: (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably transfected with Tet-pLKO-puro plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.

    Techniques Used: Modification, Liquid Chromatography with Mass Spectroscopy, Purification, Incubation, Isolation, Knock-Out, Transfection, Knockdown, Stable Transfection, shRNA, Luciferase, Control, Standard Deviation, In Vitro



    Similar Products

    96
    Addgene inc tet plko puro plasmid
    (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably <t>transfected</t> <t>with</t> <t>Tet-pLKO-puro</t> plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.
    Tet Plko Puro Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tet plko puro plasmid/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    tet plko puro plasmid - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc agei ecori site
    (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably <t>transfected</t> <t>with</t> <t>Tet-pLKO-puro</t> plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.
    Agei Ecori Site, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/agei ecori site/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    agei ecori site - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc addgene plasmid
    (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably <t>transfected</t> <t>with</t> <t>Tet-pLKO-puro</t> plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.
    Addgene Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/addgene plasmid/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    addgene plasmid - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc plasmid construction lasmids plko 1 tet
    (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably <t>transfected</t> <t>with</t> <t>Tet-pLKO-puro</t> plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.
    Plasmid Construction Lasmids Plko 1 Tet, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plasmid construction lasmids plko 1 tet/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    plasmid construction lasmids plko 1 tet - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc inducible knockdown construct
    (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably <t>transfected</t> <t>with</t> <t>Tet-pLKO-puro</t> plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.
    Inducible Knockdown Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inducible knockdown construct/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    inducible knockdown construct - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Addgene inc tet plko puro vector
    (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably <t>transfected</t> <t>with</t> <t>Tet-pLKO-puro</t> plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.
    Tet Plko Puro Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tet plko puro vector/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    tet plko puro vector - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    93
    Addgene inc control shrna plasmid shctr
    A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 <t>shRNA</t> silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).
    Control Shrna Plasmid Shctr, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control shrna plasmid shctr/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    control shrna plasmid shctr - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Addgene inc tet plko puro
    A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 <t>shRNA</t> silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).
    Tet Plko Puro, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tet plko puro/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    tet plko puro - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably transfected with Tet-pLKO-puro plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.

    Journal: bioRxiv

    Article Title: Human PARPs modify RNA nucleobases in vitro and in cells

    doi: 10.64898/2026.03.31.715305

    Figure Lengend Snippet: (A) Overview of the guanine base modification as introduced by ScARP-type toxins or by mammalian PARPs. (B) LC-MS/MS chromatograms monitoring N1-ribosyl-G in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the appearance of the peak corresponding to N1-ribosyl-G. (C) LC-MS/MS chromatograms monitoring N3-Ribosyl-U in digested total RNA from wild type (WT) and TARG1 KO HeLa cells overexpressing either EGFP alone (MOCK) or PARP15-EGFP (PARP15) fusion proteins. Arrows indicate the expected elution time for N3-ribosyl-U. (D) 5’OH-RNA oligos were ADP-ribosylated using ScARP or PARP15cat; a 5’-pRNA oligo was ADP-ribosylated using TRPT1. After purification ADP-oligos were incubated with indicated hydrolases (100 nM) at RT for 30 min. ADPr was released by incubation with 200 nM NUDT5 and AMP was measured using AMP-Glo. (E) RNA was isolated from HeLa TARG1 knock-out cells transfected with GFP or GFP-PARP15. Extracted RNA was first incubated with 100 nM TARG1 followed by NUDT5 and AMPGlo assay as in (D). (F) ADPr release from total cellular RNA isolated from indicated TARG1 knockout cell lines measured as in (D). (G) ADPr release measured as in (F) with total cellular RNA isolated from different TARG1 knockdown cell lines. TARG1 knockdown was induced in cells stably transfected with Tet-pLKO-puro plasmids containing TARG1 specific shRNA using 200 ng/ml doxycycline (72h). (H) . HEK293T cells were transfected with Gaussia luciferase (Gluc) mRNA modified by PARP15cat or control mRNA and medium was collected at indicated intervals. Translation of control Gluc mRNA (grey) is compared to ADPr-Gluc mRNA (red). Data represent baseline-subtracted translation efficiency (ΔRLU). Points represent the mean of n=4; error bars standard deviation. P-values indicate significance as determined by Welch’s t-test. (I) Endpoint analysis of in vitro translation efficiency measured after 4h incubation with non-modified Gluc mRNA and enriched ADPr-Gluc mRNA. Bars represent the mean translation efficiency (RLU) of n=3; and error bars represent standard deviation. Individual data points are shown as jittered dots. P-value indicates significance as determined by Welch’s t-test.

    Article Snippet: To make inducible TARG1 knock-down cells, TARG1 shRNA oligos were annealed and cloned into AgeI-EcoRI site of Tet-plko-Puro plasmid (Addgene 21915).

    Techniques: Modification, Liquid Chromatography with Mass Spectroscopy, Purification, Incubation, Isolation, Knock-Out, Transfection, Knockdown, Stable Transfection, shRNA, Luciferase, Control, Standard Deviation, In Vitro

    A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 shRNA silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).

    Journal: Cell Death Discovery

    Article Title: SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemia

    doi: 10.1038/s41420-026-02988-1

    Figure Lengend Snippet: A Barplot showing the expression of SPINK2 measured by qPCR in a panel of AML cell lines. n = 6 for each cell line. B Bowtie plot representing SPINK2 mRNA quantification by q-PCR following SPINK2 shRNA silencing and normalized using GAPDH ( n = 6). C Lineplot displaying cell viability upon SPINK2 knock-down determined by counting cells every 24 h for four consecutive days post shRNA induction. The results are indicative of 3 independent experiments ( n = 6). D Two-dimensional flow cytometric dot plot showing BrdU incorporation 72 hours post doxycycline induction. The three gates indicate the G0/G1, S and G2/M phases of the cell cycle. The barplot on the righthand side represent an average of three independent experiments ( n = 6). E Bowtie plot showing the percentages of Annexin V + apoptotic/necrotic cells. F Representative two-dimensional flow cytometric contour plots showing the expression levels of CD14, CD64, CD35 and CD300E in FUJIOKA cells that have undergone SPINK2 silencing 96 hours post doxycycline induction ( n = 6). The statistical analysis reported in this figure have been performed using student’s t test (*** p < 0.001, * p < 0.05).

    Article Snippet: A scrambled control shRNA plasmid (shCtr), Tet-pLKO-puro-Scrambled (Addgene plasmid #47541), was used as a non-targeting control [ ].

    Techniques: Expressing, shRNA, Knockdown, BrdU Incorporation Assay